Committed to Medical Innovations

Every day - in research labs across eastern Massachusetts - investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with these researchers to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.

World Medical Innovation Forum

WMIF LogoWe are pleased to announce the 2015 World Medical Innovation Forum. This annual gathering in Boston of more than 1,000 top innovation decision makers will focus on neurosciences and be held on April 27-29, 2015. Click here for additional details about this exciting new event.

Partners HealthCare Innovation and Pfizer’s Centers for Therapeutic Innovation (CTI) are pleased to announce a Partners-wide call for proposals of translational projects involving the development of bio-therapeutics for the treatment of Type 1 diabetes and associated conditions. In partnership with the Juvenile Diabetes Research Foundation (JDRF), CTI will support research in focus areas of immune tolerance, diabetic nephropathy and beta cell health. The pre-proposal submission deadline is Friday, Feb. 14, 2014. The pre-proposal outline can be downloaded here.

Pfizer Centers for Therapeutic Innovation 2015

We are pleased to alert you to a call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) 2015 CTI program for the development of bio-therapeutics for treatment of various diseases. CTI supports translational programs in the therapeutic areas of Inflammation, Autoimmunity, Tissue remodeling, Oncology, Cancer immunotherapy, Rare or genetic diseases, Neuroscience, Cardiovascular and metabolic diseases. Click here for additional information.

December 2014 Innovation Newsletter

May Newsletter


About Innovation

Our Mission
Leadership Team
Contact Us
LinkedIn Group 


2011 Annual Report